Try to Continue Asenapine or Lumateperone on Admission

Patients may be on new atypical antipsychotics...asenapine (Secuado, seh-KWAH-doh) or lumateperone (Caplyta, kah-PLY-tah).

There are now over a dozen of these second-generation options...with varying activity at receptors (dopamine, serotonin, etc). But efficacy seems similar.

If patients are on an asenapine patch or lumateperone at home for schizophrenia, try to continue it on admission.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals